Anticancer effect of Moringa oleifera in oral squamous cell carcinoma: a systematic review
Discover Oncology, ISSN: 2730-6011, Vol: 15, Issue: 1, Page: 688
2024
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Review Description
Background and objective: Oral squamous cell carcinoma is the most common form of mouth cancer. As plant-based medicines become increasingly popular, Moringa oleifera has been studied extensively for its plant-based components, and health benefits. The present review examined the anticancer effects of Moringa oleifera extracts on Oral squamous cell carcinoma. Materials and methods: The study complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. A comprehensive search was performed on PubMed, Scopus, and Google Scholar to find research papers published from January 2015 to August 2024 that assessed the effects of extracts of various parts of Moringa oleifera in Oral squamous cell carcinoma. Two independent reviewers separately assessed research study titles, abstracts, and the chosen full-text papers. The risk of bias in non-randomized exposure studies was classified as low, with some concerns high and extremely high. Results: The final review yielded four in-vitro investigations, two molecular analyses, and five animal models. The study revealed that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemo-preventive properties. All the 11 studies showed a low risk of bias. Conclusion: The studies reviewed herein reveal that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemopreventive properties. Although more clinical trials are needed to fully establish its efficacy and safety as a complementary therapy, the growing body of evidence positions Moringa oleifera as a promising natural adjunct to cancer treatment strategies.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85209731069&origin=inward; http://dx.doi.org/10.1007/s12672-024-01557-1; http://www.ncbi.nlm.nih.gov/pubmed/39570553; https://link.springer.com/10.1007/s12672-024-01557-1; https://dx.doi.org/10.1007/s12672-024-01557-1; https://link.springer.com/article/10.1007/s12672-024-01557-1
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know